Lead the commercial strategy, performance, competitiveness, and growth of the APAC ImmunoDerm portfolio, including TREMFYA, ICOTYDE, and future pipeline assets such as Atopic Dermatitis.

Accountable for driving portfolio growth, launch excellence, market leadership, and pipeline readiness across APAC while shaping regional priorities and influencing Global Immunology strategy.

Key Outcome: Deliver sustainable growth, successful launches, and long-term market leadership for the ImmunoDerm franchise.

L2: Main Accountabilities

1. Portfolio Strategy & Lifecycle Leadership

Lead APAC strategy across TREMFYA, ICOTYDE, and pipeline assets.
Drive portfolio prioritization and investment allocation.
Lead market shaping and launch readiness for Atopic Dermatitis and future indications.
Embed data, analytics, and insights into decision making.

2. Growth & Launch Excellence

Accelerate TREMFYA growth and market leadership.
Deliver successful launches and indication expansions for ICOTYDE.
Identify performance gaps and implement corrective actions.
Scale best practices across APAC markets.

3. Competitive Strategy & Market Leadership

Develop strategies to sustain competitive advantage.
Anticipate competitive, access, and policy risks.
Lead scenario planning and opportunity identification.
Influence Global strategy, evidence generation, and positioning.

4. Cross-Functional & Regional Leadership

Align and influence APAC Operating Companies.
Lead integration across Commercial, Medical, Market Access, Regulatory, Supply Chain, and R&D.
Ensure seamless execution from pipeline through launch and growth.

5. Performance Management & Investment Optimization

Establish portfolio KPIs and performance dashboards.
Drive accountability, resource optimization, and ROI-based decision making.
Lead forecasting and business planning processes.

6. People & Organizational Leadership

Build and develop a high-performing regional team.
Strengthen capabilities in strategy, analytics, launch excellence, and competitiveness.
Develop talent pipelines and succession plans.
Role model Credo-based leadership.

L3: Main Performance Measures

Portfolio sales and growth performance
TREMFYA market leadership and share growth
ICOTYDE launch and expansion success
Pipeline launch readiness milestones
Business plan execution
Investment and budget effectiveness
Competitive performance
Compliance and governance standards
Cross-functional and regional leadership effectiveness
Talent and capability development

L4: Qualifications & Experience

Bachelor's degree required MBA preferred.
Significant experience in Strategic Marketing, Commercial Strategy, or Sales Leadership within biopharmaceuticals.
Experience leading regional or cross-market initiatives.
Demonstrated people leadership experience.
Dermatology, Immunology, Specialty Care, or Launch Excellence experience preferred.
Strong stakeholder management and matrix leadership capabilities.
Ability to travel up to 50%.

Positioning Statement

Owns one of APSO Immunology's largest growth platforms, encompassing:

TREMFYA (core growth driver)
ICOTYDE (major launch and expansion opportunity)
Future pipeline assets, including Atopic Dermatitis

Accountable for franchise growth, launch excellence, competitive leadership, and long-term portfolio value creation across APAC, consistent with a D1 leadership role.

Qualifications

Bachelor's degree required MBA preferred
A minimum of eight (8) years of professional Sales and Sales Management or Marketing and/or Marketing Management experience within the pharmaceutical, biotech, medical device or healthcare industry is required.
A minimum of two years in Marketing and/or Marketing Management or a Commercial Excellence / Analytics function is required.
A minimum of three (3) years of experience managing and leading a cross functional / cross geographic team is strongly preferred.
Team leadership experience
Therapeutic area expertise preferred
Up to 50% travel across APAC

Director, Regional Commercial Strategy, ImmunoDerm